AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For DiDi Global, you really have to believe the company can turn intermittent profitability into something more consistent while managing its legal and regulatory overhangs. The latest Q2 2026 result, where DiDi moved back into the black with CNY 866 million of net income, strengthens the near term catalyst around improving operational discipline and supports the ongoing share buyback story, especially after a weak share price year-to-date. At the same time, the first half still showed a net loss and was affected by one-off items, so the risk that earnings remain choppy is very much alive. The proposed class action settlement and continued scrutiny of governance and board independence also hang over the equity story, even as the business shows it can produce profitable quarters again.
However, the legal settlement overhang is something investors should not ignore. DiDi Global's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be.Explore 3 other fair value estimates on DiDi Global - why the stock might be worth over 5x more than the current price!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com